Stay updated with breaking news from 91307c10. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com upgraded shares of United Therapeutics (NASDAQ:UTHR – Free Report) from a buy rating to a strong-buy rating in a research note released on Friday morning. Several other research firms also recently weighed in on UTHR. Wedbush reaffirmed an outperform rating and issued a $308.00 price objective (up previously from $307.00) on shares of United […]
Equities researchers at Wells Fargo & Company started coverage on shares of United Therapeutics (NASDAQ:UTHR – Get Free Report) in a research note issued on Friday, Briefing.com reports. The brokerage set an “overweight” rating and a $309.00 price target on the biotechnology company’s stock. Wells Fargo & Company‘s price objective would suggest a potential upside […]
PDT Partners LLC grew its position in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 46.0% during the second quarter, according to its most recent filing with the SEC. The firm owned 17,617 shares of the biotechnology company’s stock after acquiring an additional 5,548 shares during the period. PDT Partners LLC’s holdings in […]
Seaport Global Advisors LLC grew its position in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 20.8% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,545 shares of the biotechnology company’s stock after buying an additional 438 shares […]
Seaport Global Advisors LLC increased its position in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 20.8% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,545 shares of the biotechnology company’s stock after buying an additional 438 shares during […]